Paradigm-shifting research into Tregs and peripheral immune tolerance helped launch entire spaces of therapeutic development, including cancer immunotherapy, organ transplant rejection and autoimmune disease. Almost 30 years after their foundational discoveries, the recipients of the 2025 Nobel Prize in Physiology or Medicine are still researching and advancing the use of Treg-based therapies in autoimmune and inflammatory diseases.
